Combined low calcium and lack magnesium is a risk factor for motor deficit in mice

Bioscience, Biotechnology and Biochemistry

Volumn 77, Issue 2, 2013, Pages 266-270

  Taniguchi, Ryoo ^a   Nakagawasai, Osamu ^a   Tan No, Koichi ^a   Yamadera, Fumihiro ^a   Nemoto, Wataru ^a   Sato, Shoko ^a   Yaoita, Fukie ^a   Tadano, Takeshi ^a,b  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Calcium; Catalepsy; Dopamine; Magnesium

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CATALEPSY; DOPAMINE; DOPAMINERGIC NEURONS; IMMUNOHISTOCHEMICAL STAINING; NEURODEGENERATIVE DISORDERS; PARKINSONIAN SYMPTOMS; TYROSINE HYDROXYLASE;

AMINES; AMINO ACIDS; ANTIVIRAL AGENTS; CALCIUM; MAGNESIUM; NEURODEGENERATIVE DISEASES; NEURONS; NUTRITION;

MAMMALS;

AMANTADINE; ANTIPARKINSON AGENT; BENSERAZIDE; BROMOCRIPTINE; CALCIUM; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MAGNESIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; CATALEPSY; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; ELEMENTAL DIET; ENZYMOLOGY; MAGNESIUM DEFICIENCY; MALE; METABOLISM; MOUSE; PARKINSON DISEASE; RISK FACTOR; SUBSTANTIA NIGRA;

AMANTADINE; ANIMALS; ANTIPARKINSON AGENTS; BENSERAZIDE; BROMOCRIPTINE; CALCIUM; CATALEPSY; DOPAMINE AGONISTS; FOOD, FORMULATED; LEVODOPA; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MICE; PARKINSON DISEASE, SECONDARY; RECEPTORS, DOPAMINE; RISK FACTORS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

MUS; PARKINSONIA;

EID: 84875441067     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.120671     Document Type: Article

References (34)

1. Olanow CW and Arendash GW, Curr. Opin. Neurol., 7,548-558(1994).
2. Yasui M, Kihira T, and Ota K, Neurotoxicology, 13,593-600(1992).
3. Durlach J, Bac P, Durlach V, Durlach A, Bara M, and Guiet-Bara A, Magnes. Res., 10,339-353(1997).
4. Purdey M, Med. Hypotheses, 63,793-809(2004).
5. Yasui M, Ota K, and Garruto RM, Neurotoxicology, 16,511-517(1995).
6. Oyanagi K, Kawakami E, Kikuchi-Horie K, Ohara K, Ogata K, Takahama S, Wada M, Kihira T, and Yasui M, Neuropathology, 26,115-128(2006).
7. Nakagawasai O, Yamadera F, Iwasaki K, Asao T, Tan-No K, Niijima F, Arai H, and Tadano T, Behav. Brain Res., 177,315-321(2007).
8. Sato A, Nakagawasai O, Tan-No K, Onogi H, Niijima F, and Tadano T, Behav. Brain Res., 215,141-145(2010).
9. Rico MC, Lerma A, Planells E, Aranda P, and Gonzalez JL, Int. J. Vitam. Nutr. Res., 65,122-126(1995).
10. Nemoto T, Matsuzaki H, Uehara M, and Suzuki K, Magnes. Res., 19,19-27(2006).
11. Ross RT, Can. J. Neurol. Sci., 17,155-162(1990).
12. Schmidt WJ and Kretschmer BD, Neurosci. Biobehav. Rev., 21,381-392(1997).
13. Iuvone PM, J. Neurochem., 43,1359-1368(1884).
14. Hashimoto T, Nishi K, Nagasao J, Tsuji S, and Oyanagi K, Brain Res., 1197,143-151(2008).
15. Nakamura K, Bindokas VP, Marks JD, Wright DA, Frim DM, Miller RJ, and Kang UJ, Mol. Pharmacol., 58,271-278(2000).
16. Yasui M, Yano I, Yase Y, and Ota K, J. Neurol. Sci., 105,206-210(1991).
17. Garruto RM, Shankar SK, Yanagihara R, Salazar AM, Amyx HL, and Gajdusek DC, Acta Neuropathol., 78,210-219(1989).
18. Strong MJ, "Mineral and Metal Neurotoxicology", eds. Yasui M, Strong MJ, Ota K, and Verity MA, CRC Press, Boca Raton, pp. 99-106 (1996).
19. Komatsu F, Kagawa Y, Kawabata T, Kaneko Y, Chimedregzen U, Purvee B, and Otgon J, Curr. Aging Sci., 4,42-56(2011).
20. Mena I, Marin O, Fuenzalida S, and Cotzias GC, Neurology, 17,128-136(1967).
21. Pentschew A, Ebner FF, and Kovatch RM, J. Neuropathol. Exp. Neurol., 22,488-499(1963).
22. Mustafa SJ and Chandra SV, J. Neurochem., 18,931-933(1971).
23. Neff NH, Barrett RE, and Costa E, Experientia, 25,1140-1141(1969).
24. Cotzias GC, Papavasiliou PS, Ginos J, Steck A, and Düby S, Annu. Rev. Med., 22,305-326(1971).
25. Verity MA, Neurotoxicology, 20,489-497(1999).
26. Nowak P, Bojanek K, Szkilnik R, Jośko J, Boroń D, Adwent M, Gorczyca P, Kostrzewa RM, and Brus R, Neurotox. Res., 19,536-543(2011).
27. Mayer ML, Westbrook GL, and Guthrie PB, Nature, 309,261-263(1984).
28. Schrattenholz A and Soskic V, Curr. Top. Med. Chem., 6,663-686(2006).
29. Lin JY, Chung SY, Lin MC, and Cheng FC, Life Sci., 71,803-811(2002).
30. Nowak L, Bregestovski P, Ascher P, Herbet A, and Prochiantz A, Nature, 307,462-465(1984).
31. Elliott PJ, Close SP, Walsh DM, Hayes AG, and Marriott AS, J. Neural Transm. Park. Dis. Dement. Sect., 2,91-100(1990).
32. Mele A, Thomas DN, and Pert A, Neuroscience, 82,43-58(1998).
33. Morelli M, Fenu S, Pinna A, and Di Chiara G, J. Pharmacol. Exp. Ther., 260,402-408(1992).
34. Ossowska K, J. Neural Transm. Park. Dis. Dement. Sect., 8,39-71(1994).